Related Experiment Video
Updated: May 17, 2026
13:22
Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays
Published on: October 23, 2019
Revealing Imatinib-Kinase Specificity via Analyzing Changes in Protein Dynamics and Computing Molecular Binding
William Troxel1, Emily Vig2, Chia-En A Chang1,2
1Department of Chemistry, University of California, Riverside, California 92521, United States.
The Journal of Physical Chemistry. B
|May 15, 2026
Summary
Drug promiscuity allows for drug repurposing. This study uses molecular dynamics to predict imatinib-kinase binding specificity by analyzing protein-ligand interactions and protein dynamics.
Area of Science:
- Biochemistry and Molecular Dynamics
- Pharmacology and Drug Discovery
- Computational Biology
Background:
- Drug promiscuity, where a single drug targets multiple proteins, can offer therapeutic benefits or cause toxicity.
- Imatinib is a kinase inhibitor known to bind to various kinases with differing affinities, but its precise binding determinants remain unclear.
- Understanding these determinants is crucial for drug repurposing and designing new high-affinity binders.
Purpose of the Study:
- To elucidate the molecular mechanisms governing imatinib's binding specificity across different kinases.
- To develop a predictive computational approach for forecasting drug-target interactions and binding affinities.
- To explore the potential of drug repurposing by understanding off-target binding.
Main Methods:
- All-atom molecular dynamics simulations in explicit solvent.
- Analysis of molecular thermodynamics, force distribution, and residue side chain dihedral correlations.
- Principal component analysis to identify key protein dynamics and interactions.
Main Results:
- Simulations accurately reproduced experimental imatinib-kinase affinity data.
- Identified global protein networks, side chain dihedral correlations, and secondary motif dynamics as key predictors of binding specificity.
- Correlated changes in protein dynamics and residue correlations with imatinib affinity, distinguishing high- and low-affinity binders.
- The side chain dihedral correlation network identified known mutations affecting imatinib sensitivity.
Conclusions:
- Computational methods, including residue correlation and force interactions, can effectively predict imatinib-kinase binding specificity.
- This study provides a framework for repurposing existing drugs and designing novel high-affinity binders for specific targets.
- Understanding protein-ligand interactions and dynamic motions is essential for optimizing drug efficacy and minimizing off-target effects.
